Clinical outcomes of bleomycin electrosclerotherapy (BEST) for the treatment of slow-flow vascular malformations (SFVMs): a UK single-centre experience

Nicolò Ubaldi, Arjan Singh Khattar, Mathew Storey, John Adu, Leto Mailli, Robert Morgan, Tobian Muir, Lakshmi Ratnam · 2026

Read Clinical outcomes of bleomycin electrosclerotherapy (BEST) for the treatment of slow-flow vascular malformations (SFVMs): a UK single-centre experience by Nicolò Ubaldi, Arjan Singh Khattar, Mathew Storey, John Adu, Leto Mailli, Robert Morgan, Tobian Muir, Lakshmi Ratnam (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13473054.txt.

Description

Nicolò Ubaldi and a team of co-authors report results for a new treatment of slow-flow vessel malformations in the United Kingdom, in two thousand twenty-six. The treatment injects a drug into the lesion, then applies electric pulses to help the drug enter cells. Twenty patients with symptoms were treated at one center over about two years.

Forty-two procedures were done, most on the face. Symptom and quality-of-life scores improved clearly by follow-up, with swelling, appearance, and pain improving most. No major complications occurred. Skin marks and mouth ulcers were the main side effects, and both faded or healed. Even a single session helped, while repeated sessions helped more.

Catalog record

CREATORNicolò Ubaldi, Arjan Singh Khattar, Mathew Storey, John Adu, Leto Mailli, Robert Morgan, Tobian Muir, Lakshmi Ratnam
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13473054

Browse the full library · About the Tower of Babel